
|Articles|September 27, 2006
Serono, Inc. Names Paul Lammers Chief Medical Officer
Author(s)BioPharm International Editors
Serono, Inc. (Rockland, MA, www.serono.com) has named Paul Lammers, MD, as its US Chief Medical Officer.
Advertisement
Serono, Inc. (Rockland, MA,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Next-Generation Modalities Drive New Antibody Discovery
2
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
3
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
4
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
5




